Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection
Elecsys ® HBeAg quant is an immunoassay that can be used as an early marker of acute hepatitis B infection, as well as an indicator of chronic active hepatitis in combination with other laboratory results and clinical information.The single test will inform clinicians if treatment is required and regimens are working in conjunction with other diagnostic assays.Almost 300 million people globally have chronic hepatitis B, causing a significant burden to health systems as it puts patients at high risk of death from cirrhosis and liver cancer.1Basel, 27 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the la...
Source: Roche Media News - November 27, 2023 Category: Pharmaceuticals Source Type: news
AI algorithm helps determine status of small renal lesions
CHICAGO -- A deep-learning AI algorithm designed to determine the malignancy status of renal lesions less than 4 cm could reduce overtreatment and undertreatment of kidney cancer, according to research presented November 26 at RSNA 2023.The AI functions by taking a preoperative CT scan as input, localizes the tumor region by segmenting it, and then predicts the probability of malignancy in a fully automated fashion, according to Aakanksha Rana, PhD, of Johnson & Johnson in New Brunswick, NJ.“The outcome was good given our small dataset,” Rana said, adding that there is much work to be done. “It’s very surprising to...
Source: AuntMinnie.com Headlines - November 26, 2023 Category: Radiology Authors: Liz Carey Tags: Resources Conference RSNA 2023 Source Type: news
Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma
(MedPage Today) -- Adding immunotherapy to neoadjuvant chemotherapy for resectable gastroesophageal cancer led to higher rates of disease downstaging and pathologic complete response (pCR), an exploratory analysis of a randomized trial showed... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 24, 2023 Category: Gastroenterology Source Type: news
Direct-Acting Antivirals Still Underused in Hep C-Related Liver Cancer
TUESDAY, Nov. 21, 2023 -- Direct-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver Meeting, the annual meeting of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2023 Category: Pharmaceuticals Source Type: news
Increasing Generational Status Linked to Elevated Risk for Liver Cancer
MONDAY, Nov. 20, 2023 -- For Mexican Americans, increasing generational status is associated with an increased risk for hepatocellular carcinoma (HCC), according to a study published online Nov. 20 in Cancer.Nicholas Acuna, M.P.H., from the Keck... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2023 Category: Pharmaceuticals Source Type: news
ASTRO proposes new guidelines for aggressive breast cancer and DCIS
The American Society for Radiation Oncology (ASTRO) has released a proposed update to clinical practice guidelines for partial breast radiation as an alternative to whole breast radiation for early-stage invasive breast cancer and ductal carcinoma in situ (DCIS).
ASTRO’s recommendations are based on evidence from major clinical trials, said Janice Lyons, MD, chair of the guideline task force at the University Hospitals Seidman Cancer Center in Cleveland, OH, in a statement released by the society. The new guidance also addresses aspects related to the technical delivery of partial breast irradiation (PBI), including do...
Source: AuntMinnie.com Headlines - November 17, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Subspecialties Radiation Oncology Source Type: news
Treatment of Favorable-Risk Advanced Renal Cell Carcinoma Treatment of Favorable-Risk Advanced Renal Cell Carcinoma
Experts discuss strategies for treating patients with favorable-risk advanced renal cell carcinoma in light of IMDC guidelines and recent prospective studies.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 17, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
ASTRO Updates Guidelines on Partial Breast Irradiation for Early Invasive Cancer
(MedPage Today) -- The American Society for Radiation Oncology (ASTRO) updated their guidelines on partial breast irradiation (PBI) for patients with early-stage invasive breast cancer or ductal carcinoma in situ (DCIS).
These new guidelines take... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 16, 2023 Category: Hematology Source Type: news
'We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinoma
(MedPage Today) -- NASHVILLE, Tenn. -- Chimeric antigen receptor (CAR) T-cell therapy has the potential to become standard-of-care therapy for renal cell carcinoma (RCC) that does not respond to current therapies, an RCC specialist said here... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 16, 2023 Category: Hematology Source Type: news
Road to RSNA 2023: Molecular Imaging
This is just the third year that RSNA has offered a dedicated track on nuclear medicine and molecular imaging, with eight scientific sessions covering research in prostate cancer imaging, breast cancer, cardiovascular and pulmonary imaging, and more. There will be also 30 educational courses and 14 poster sessions. Notably, this is the first year a scientific session is being offered that covers advances in AI in nuclear medicine. Presentations on PET imaging in prostate cancer – an approach that is witnessing widespread adoption – include an array of studies on prostate-specific membrane antigen (PSMA)-based radiotrac...
Source: AuntMinnie.com Headlines - November 15, 2023 Category: Radiology Authors: Will Morton Tags: 2023 2023 Molecular Imaging Preview Source Type: news
F-18 fluciclovine vs. Ga-68 PSMA: Which tracer is superior in metastatic breast cancer?
Monday, November 27 | 8:40 a.m.-8:50 a.m. | M1-SSNMMI02-5 | Room E350F-18 fluciclovine PET/CT imaging results in greater metastases detection in women with invasive lobular carcinoma (ILC) of the breast than gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-PET/CT, while both are superior to conventional imaging, according to this presentation.Presenter Aliza Mushtaq, MD, a postdoc research fellow at Emory University, will discuss a study comparing the use of the two PET radiotracers versus conventional imaging (CT and bone scans) in 20 women with de novo or suspected recurrent ILC.Conventional imaging detected ...
Source: AuntMinnie.com Headlines - November 15, 2023 Category: Radiology Authors: Will Morton Tags: 2023 Molecular Imaging Preview Source Type: news
Targeting New Pathways to Improve Outcomes in Renal Cell Carcinoma
(MedPage Today) -- NASHVILLE, Tenn. -- Building on the existing immune checkpoint inhibitor (ICI) platform, new treatment strategies for renal cell carcinoma (RCC) seek to adapt the cancer's immunity cycle to inform development of more effective... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 15, 2023 Category: Hematology Source Type: news
Renal Cell Carcinoma Highlights From ESMO 2023 Renal Cell Carcinoma Highlights From ESMO 2023
Dr Brian Rini reviews key studies on renal cell carcinoma from ESMO 2023, including several LITESPARK trials examining belzutifan, and the RENOTORCH trial from China looking at a IO/TKI combination.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news
Road to RSNA 2023: Ultrasound
Ultrasound's utility will be on full display at this year's RSNA annual meeting, showing its merit in a wide variety of clinical applications. Research to be presented at the annual meeting in Chicago will explore the modality's clinical applications in musculoskeletal, pediatric, abdominal, and women's imaging among other areas. This includes advancements in ultrasound in recent years, such as the use of contrast for improved imaging, elastography and color Doppler for assessing complex pathologies, and using imaging data in AI models. Studies will also evaluate ways to further improve the modality's capabilities by rea...
Source: AuntMinnie.com Headlines - November 14, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: 2023 2023 Ultrasound Preview Source Type: news
Ultrasound model predicts liver cancer risk
Thursday, November 30 | 2:20 p.m.-2:30 p.m. | R6-SSGI19-6 | Room E352A model integrating clinical and surveillance ultrasound features for patients at high risk of hepatocellular carcinoma will be presented in this session.In his talk, Yeun-Yoon Kim, MD, from Yonsei University in South Korea will present research that demonstrates how this model has superior performance compared with previously reported risk scoring systems in this area.Predicting risk for hepatocellular carcinoma would help with triaging and strategizing best treatment options. Models integrating ultrasound features are being developed to help with suc...
Source: AuntMinnie.com Headlines - November 14, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: 2023 Ultrasound Preview Source Type: news
